Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Klein

Showing results (1231-1240 of 1,374) with videos related to

Pageof 138
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2020
Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and CanadaPeter F Rebeiro, Cathy A Jenkins, Aihua Bian, et al.
AIDS (London, England)|February 19, 2025
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virusMathieu Chalouni, Daniela K Van Santen, Juan Berenguer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasMarina B Klein, Keri N Althoff, Yuezhou Jing, et al.
Open Forum Infectious Diseases|September 2, 2025
Direct-Acting Antiviral Initiation Among People With Hepatitis C Virus (HCV) and HIV on Antiretroviral Therapy in the United States and Canada: Factors Driving the HCV Treatment GapRaynell Lang, Elizabeth Humes, Asya Lyass, et al.
Hepatology (Baltimore, Md.)|March 29, 2021
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North AmericaH Nina Kim, Craig W Newcomb, Dean M Carbonari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2012
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North AmericaMichael J Silverberg, Bryan Lau, Amy C Justice, et al.
Annals of Internal Medicine|September 5, 2012
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008Keri N Althoff, Kate Buchacz, H Irene Hall, et al.
AIDS (London, England)|March 25, 2026
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIVMathieu Chalouni, Jessie Torgersen, Christopher T Rentsch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2025
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIVDaniela K van Santen, Mathieu Chalouni, Juan Berenguer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2015
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected PersonsLaurence Brunet, Erica E M Moodie, Jim Young, et al.
Pageof 138

Showing results (1231-1240 of 1,374) with videos related to

Sort By:
Pageof 138
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2020
Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and CanadaPeter F Rebeiro, Cathy A Jenkins, Aihua Bian, et al.
AIDS (London, England)|February 19, 2025
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virusMathieu Chalouni, Daniela K Van Santen, Juan Berenguer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasMarina B Klein, Keri N Althoff, Yuezhou Jing, et al.
Open Forum Infectious Diseases|September 2, 2025
Direct-Acting Antiviral Initiation Among People With Hepatitis C Virus (HCV) and HIV on Antiretroviral Therapy in the United States and Canada: Factors Driving the HCV Treatment GapRaynell Lang, Elizabeth Humes, Asya Lyass, et al.
Hepatology (Baltimore, Md.)|March 29, 2021
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North AmericaH Nina Kim, Craig W Newcomb, Dean M Carbonari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2012
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North AmericaMichael J Silverberg, Bryan Lau, Amy C Justice, et al.
Annals of Internal Medicine|September 5, 2012
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008Keri N Althoff, Kate Buchacz, H Irene Hall, et al.
AIDS (London, England)|March 25, 2026
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIVMathieu Chalouni, Jessie Torgersen, Christopher T Rentsch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2025
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIVDaniela K van Santen, Mathieu Chalouni, Juan Berenguer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2015
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected PersonsLaurence Brunet, Erica E M Moodie, Jim Young, et al.
Pageof 138